Paediatric ECAT protocol

Adrenal insufficiency

P5.1 Published: December 2023 Printed on 19 May 2024

QR code link to ECI website

Get the latest version


Any person, 4 weeks to 15 years, presenting with a previous diagnosis of adrenal insufficiency who presents as unwell. This excludes a newly diagnosed patient in the ED. To be used in conjunction with primary presenting protocol.

This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.

Unstable or seriously unwell (adrenal crisis)

  • Prioritise giving hydrocortisone.
  • Escalate care urgently as per local CERS protocol.
  • Follow the patient’s management plan if available.

History prompts, signs and symptoms

These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.

History prompts

  • Presenting complaint
  • Onset of symptoms
  • Pain assessment
  • Recent illness or injury
  • Fluid intake and output
  • Pre-hospital treatment. Oral and IV hydrocortisone doses taken on sick days
  • Pregnancy
  • Last menstrual period
  • Past admissions
  • Medical and surgical history
  • Current medications
  • Immunisation status
  • Current weight

Signs and symptoms

  • Lethargy
  • Pain
  • Diarrhoea and vomiting
  • Dehydration
  • Nausea
  • Poor appetite
  • Fever
  • Emotional stress

Red flags

Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.

Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.

Historical

  • Patient management plan not reviewed within the last 12 months
  • Recent or prolonged oral corticosteroid use

Clinical

  • Altered level of consciousness
  • Confusion
  • Drowsiness
  • Seizure
  • Major injury
  • Pallor
  • Hypotension
  • Dehydration
  • Diarrhoea and vomiting
  • Hypoglycaemia

Remember child or adolescent at risk: patient or carer concern, suspected non-accidental injury or neglect, multiple comorbidities or unplanned return.

Clinical assessment and specified intervention (A to G)

If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.

Position

AssessmentIntervention

General appearance/first impressions

Position of comfort

Airway

AssessmentIntervention

Patency of airway

Maintain airway patency

Consider airway opening manoeuvres and positioning

Breathing

AssessmentIntervention

Respiratory rate and work of breathing

Consider auscultation of chest (breath sounds)

Oxygen saturation (SpO2)

Assist ventilation as clinically indicated

Apply oxygen to maintain SpO2 over 93%

Circulation

AssessmentIntervention

Perfusion (capillary refill, skin warmth and colour)

Heart rate

Blood pressure

Assess circulation

Attach cardiac monitor if BP/HR are within the Yellow or Red Zones, or where clinically relevant, e.g. irregular pulse, palpitations, syncope, shock, respiratory compromise, cardiac history or clinical concern

Consider 12 lead ECG

Ensure a full set of observations has been documented before giving hydrocortisone

Unstable or unwell

  • Hypotension
  • Tachycardia
  • Vomiting
  • Diarrhoea
  • Drowsy

Insert IV cannula, if trained

Give hydrocortisone as per patient's management plan

If the plan is unavailable, give hydrocortisone IV/IM, once only:

  • Less than 8 kg: 25 mg
  • 8–12 kg: 50 mg
  • 12–30 kg: 75 mg
  • Over 30 kg: 100 mg

Do not delay hydrocortisone. Use the IM route if IV access is unavailable.

Consider sepsis in the unstable or unwell child

Signs of shock:

tachycardia and CRT 3 seconds and over

and/or abnormal skin perfusion

and/or hypotension

If signs of shock present or moderate to severe dehydration, give sodium chloride 0.9% at 20 mL/kg IV/intraosseous bolus once only, maximum dose 1000 mL

Moderately unwell

  • Fever 38°C and over
  • Moderate illness or injury
  • Mild vomiting and/or diarrhoea

Give hydrocortisone as per patient's management plan, if available

If vomiting persists, consider imminent adrenal crisis and treat as unstable or unwell

Mildly unwell

  • Fever less than 38°C
  • Tolerating oral intake
  • Appears well
Continue A to G assessment

Disability

AssessmentIntervention
AVPU

If AVPU shows reduced level of consciousness, continue to assess GCS, pupillary response and limb strength

GCS, pupillary response and limb strength

Obtain baseline and repeat assessment as clinically indicated

Pain

Assess pain. If indicated, give early analgesia as per analgesia section then resume A to G assessment

Exposure

AssessmentIntervention
Temperature

Measure temperature

Head-to-toe assessment, including posterior surfaces

Check and document any abnormalities

Fluids

AssessmentIntervention

Hydration status

Assess fluids, in and out. Document on fluid balance chart. Include gastrointestinal losses
Nausea and/or vomiting If present, see nausea and/or vomiting section

Glucose

Assessment Intervention

BGL

Measure BGL. See medication table for 40% glucose gel dosing

If BGL between 2 mmol/L and 3 mmol/L and NOT symptomatic (Yellow Zone criteria):

  • give quick-acting carbohydrate:
    • Up to 12 months: milk feed and/or 40% glucose gel buccal
    • 12 months and over: sugary soft drink or fruit juice or 40% glucose gel buccal
  • reassess BGL in 15–30 minutes and repeat treatment until BGL over 3 mmol/L

If BGL less than 2 mmol/L OR symptomatic (Red Zone criteria) OR unable to tolerate oral glucose:

  • give 40% glucose gel buccally in incremental doses, as tolerated, while establishing IV access
  • give 10% glucose, 2 mL/kg by slow IV injection once only
  • if IV access delayed, give:
    • Up to 25 kg: glucagon 0.5 mg IM, once only
    • 25 kg and over: glucagon 1 mg IM, once only
  • reassess BGL in 15 minutes

Once stabilised, give patient long-acting carbohydrate and continue to check BGL hourly, or as clinically indicated

Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.

Focused assessment

Complete a dehydration focused assessment.

Complete the focused assessment in conjunction with the primary presenting problem.

Precautions and notes

  • Adrenal crisis most commonly occurs in the context of an intercurrent injury or illness.
  • Manage the cause of the adrenal crisis concurrently.
  • Steroid and fluid replacement, plus close monitoring and management of glucose and potassium levels, are a priority.
  • The adrenal crisis triad involves low serum sodium, high serum potassium and low serum glucose.
  • Some patients may arrive with individual hydrocortisone for injection vials. These are safe to use.

Interventions and diagnostics

Specific treatment

Manage adrenal insufficiency as priority, and consider second ECAT protocol for primary presenting problem.


Analgesia

If pain score 1–6 (mild–moderate): give paracetamol 15 mg/kg orally once only, maximum dose 1000 mg

If severe pain present, give analgesia and escalate as per local CERS protocol.

Consider non-pharmacological pain relief (appendix).


Nausea and/or vomiting

If nausea and/or vomiting is present and over 6 months give:

ondansetron:

  • 8–15 kg: 2 mg, orally once only
  • 15–30 kg: 4 mg, orally once only
  • Over 30 kg: 8 mg, orally once only.

Procedural analgesia

For pain relief required during procedures only, not used to replace appropriate analgesia.

Sucrose 24%

  • 1–18 months: give 1–2 mL orally per procedure
  • Maximum dose:
    • 1–3 months: up to 5 mL in 24 hours
    • 3–18 months: up to 10 mL in 24 hours.

Repeat as needed up to the maximum dose.


Radiology

Radiology will depend on the working diagnosis. It needs to be requested by a medical or nurse practitioner. If there is concern for urgent radiology, escalate as per local CERS protocol.


Pathology

  • FBC, UEC, VBG, glucose

Medications

The patient’s weight is mandatory for calculating fluid and medication doses.

The Broselow Tape or APLS weight table (appendix) can be used only in circumstances where the patient cannot be weighed.

The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.

Drag the table right to view more columns or turn your phone to landscape

Drug Dose Route Frequency

Up to 25 kg:
0.5 mg

25 kg and over:
1 mg

IM

Once only

2 mL/kg

Slow IV injection

Once only

Glucose 40% gel
(0.4 g/mL)

4 weeks1 year:
200 mg/kg (=0.5 mL/kg)

15 years: 5 g

611 years: 10 g

12 years and over : 15 g

Buccal

Repeat after 15 minutes if required

Less than 8 kg:
25 mg

8–12 kg:
50 mg

12–30 kg:
75 mg

Over 30 kg:
100 mg

IV or IM, if IV not accessible

Give dose based on management plan if available

Once only. May require further dose after consultation

Over 6 months and 8–15 kg:
2 mg

15–30 kg:
4 mg

Over 30 kg:
8 mg

Oral

Once only

Oxygen

0.25–15 L/min, device dependent

Inhalation

Continuous

Paracetamol H

15 mg/kg

Maximum dose 1000 mg

Oral

Pain score 1–10

Once only

20 mL/kg

Maximum dose 1000 mL

IV/intraosseous

Bolus

Once only

Sucrose 24%

1–18 months:
1–2 mL per procedure

Maximum dose
1–3 months:
Up to 5 mL in 24 hours

3–18 months:
Up to 10 mL in 24 hours

Oral

Used during procedures only

Repeat if required to maximum dose

Medications with contraindications or requiring dose adjustment are marked:

  • H for patients with known hepatic impairment
  • R for patients with known renal impairment.

Escalate to medical or nurse practitioner.

References

Hide references

Evidence informed

Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process.

Collaboration

This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol.

Currency Due for review: Jan 2026. Based on a regular review cycle.
Feedback Email ACI-ECIs@health.nsw.gov.au

Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/paediatric/adrenal-insufficiency

Back to top